中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
8期
1852-1854
,共3页
李少珂%张鹃鹃%王立成%王海彦%朱方涛
李少珂%張鵑鵑%王立成%王海彥%硃方濤
리소가%장견견%왕립성%왕해언%주방도
大黄素%心肌缺血%再灌注损伤%脱噬作用
大黃素%心肌缺血%再灌註損傷%脫噬作用
대황소%심기결혈%재관주손상%탈서작용
Emodin%Myocardial ischemia%Reperfusion injury%Apoptosis
目的 观察经过大黄素预处理对大鼠心肌细胞缺血再灌注损伤的保护作用.方法 将30只健康SD雄性大鼠随机分为5组,即假手术组(A组,n=6)、心肌缺血再灌注损伤模型组(B组,n=6)、大黄素灌胃预处理组(C组:20 mg/kg;D组:40 mg/kg;E组:60 mg/kg).除A组外均建立在体大鼠心肌缺血再灌注损伤模型.采用苏木素-伊红(HE)染色法观察心肌细胞病理学改变;反转录-聚合酶链反应(RT-PCR)法测定凋亡相关基因B细胞淋巴瘤/白血病-2 (bcl-2)、bcl-2相关X蛋白(bax)、半胱氨酰天冬氨酸特异性蛋白酶(Caspase)-3 mRNA表达水平,检测大鼠心肌组织中超氧化物歧化酶(SOD)、丙二醛(MDA)水平的变化.结果 与A组比较,B组和各预处理组均出现明确的心肌缺血和心肌梗死区域;各预处理组心肌细胞中bcl-2 mRNA表达水平以及SOD、MDA活性均较B组[(1.73±0.21)、(33.15 ±3.51) U/(mg·pro)]显著提高(P<0.01),bax和Caspase-3的mRNA表达水平以及MDA含量较B组[(4.70±0.37)、(4.61±0.52)、(6.87±0.34) nmol/(mg· pro)]明显降低(P<0.01).结论 大黄素能够一定程度抑制缺血再灌注损伤诱导的心肌细胞凋亡作用,减轻再灌注造成的损伤,具有较好的心肌保护作用.
目的 觀察經過大黃素預處理對大鼠心肌細胞缺血再灌註損傷的保護作用.方法 將30隻健康SD雄性大鼠隨機分為5組,即假手術組(A組,n=6)、心肌缺血再灌註損傷模型組(B組,n=6)、大黃素灌胃預處理組(C組:20 mg/kg;D組:40 mg/kg;E組:60 mg/kg).除A組外均建立在體大鼠心肌缺血再灌註損傷模型.採用囌木素-伊紅(HE)染色法觀察心肌細胞病理學改變;反轉錄-聚閤酶鏈反應(RT-PCR)法測定凋亡相關基因B細胞淋巴瘤/白血病-2 (bcl-2)、bcl-2相關X蛋白(bax)、半胱氨酰天鼕氨痠特異性蛋白酶(Caspase)-3 mRNA錶達水平,檢測大鼠心肌組織中超氧化物歧化酶(SOD)、丙二醛(MDA)水平的變化.結果 與A組比較,B組和各預處理組均齣現明確的心肌缺血和心肌梗死區域;各預處理組心肌細胞中bcl-2 mRNA錶達水平以及SOD、MDA活性均較B組[(1.73±0.21)、(33.15 ±3.51) U/(mg·pro)]顯著提高(P<0.01),bax和Caspase-3的mRNA錶達水平以及MDA含量較B組[(4.70±0.37)、(4.61±0.52)、(6.87±0.34) nmol/(mg· pro)]明顯降低(P<0.01).結論 大黃素能夠一定程度抑製缺血再灌註損傷誘導的心肌細胞凋亡作用,減輕再灌註造成的損傷,具有較好的心肌保護作用.
목적 관찰경과대황소예처리대대서심기세포결혈재관주손상적보호작용.방법 장30지건강SD웅성대서수궤분위5조,즉가수술조(A조,n=6)、심기결혈재관주손상모형조(B조,n=6)、대황소관위예처리조(C조:20 mg/kg;D조:40 mg/kg;E조:60 mg/kg).제A조외균건립재체대서심기결혈재관주손상모형.채용소목소-이홍(HE)염색법관찰심기세포병이학개변;반전록-취합매련반응(RT-PCR)법측정조망상관기인B세포림파류/백혈병-2 (bcl-2)、bcl-2상관X단백(bax)、반광안선천동안산특이성단백매(Caspase)-3 mRNA표체수평,검측대서심기조직중초양화물기화매(SOD)、병이철(MDA)수평적변화.결과 여A조비교,B조화각예처리조균출현명학적심기결혈화심기경사구역;각예처리조심기세포중bcl-2 mRNA표체수평이급SOD、MDA활성균교B조[(1.73±0.21)、(33.15 ±3.51) U/(mg·pro)]현저제고(P<0.01),bax화Caspase-3적mRNA표체수평이급MDA함량교B조[(4.70±0.37)、(4.61±0.52)、(6.87±0.34) nmol/(mg· pro)]명현강저(P<0.01).결론 대황소능구일정정도억제결혈재관주손상유도적심기세포조망작용,감경재관주조성적손상,구유교호적심기보호작용.
Objective To investigate the protective effects of emodin on myocardial ischemia-reperfusion injury (MIRI) in rats.Methods Thirty health male Sprague-Dawley rats were randomly divided into five groups:sham group (group A),ischemia-reperfusion group (group B),emodin preconditioning groups (group C:20 mg/kg;group D:40 mg/kg;group E:60 mg/kg).The rat MIRI models in vivo was established successfully.Hematoxylin-eosinstaining (HE) method was used to identify the pathologic changes of myocardial tissue.The mRNA expression levels of B cell lymphoma/leukemia-2 (bcl-2),bcl-2 associated X protein (bax) and cysteinyl aspartate-specific protease-3 (Caspase-3) were determined by reverse transcription polymerase chain reaction (RT-PCR).The activities of superoxide dismutase (SOD) and the content of malondialdehyde (MDA) were examined.Results Clear myocardial ischemia and myocardial infarction area was found in groups B,C,D and E.As compared with the group B [(1.73 ±0.21),(33.15 ± 3.51) U/(mg· pro)],the expression of bcl-2 mRNA and the activity of SOD were increased in groups C,D and E (P < 0.01).The levels of bax and Caspase-3,and the content of MDA were significantly decreased (P <0.01) in groups C,D and E as compared with the group B [(4.70±0.37),(4.61 ±0.52),(6.87 ±0.34) nmol/(mg·pro)].Conclusion Emodin can inhibit the apoptosis of myocardium induced by MIRI to some extent and alleviate the inchemic reperfusion-induced injury.